Tokyo Tape
Sign in
← Chiome Bioscience

Quarterly report · Q2

4583.TEDINET S100S9VE
Period2023-01-01 → 2023-06-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed

Amends S100RN56.

Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥359m2023-01-01 → 2023-06-30StandaloneNet sales
Revenue¥631m2022-01-01 → 2022-12-31StandaloneNet sales (5-year summary)
Revenue¥278m2022-01-01 → 2022-06-30StandaloneNet sales
Operating income−¥659m2023-01-01 → 2023-06-30StandaloneOperating income
Operating income−¥779m2022-01-01 → 2022-06-30StandaloneOperating income
Ordinary income−¥662m2023-01-01 → 2023-06-30StandaloneOrdinary income
Ordinary income−¥1.2bn2022-01-01 → 2022-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥769m2022-01-01 → 2022-06-30StandaloneOrdinary income
Profit before tax−¥661m2023-01-01 → 2023-06-30StandaloneIncome before income taxes
Profit before tax−¥769m2022-01-01 → 2022-06-30StandaloneIncome before income taxes
Net income−¥664m2023-01-01 → 2023-06-30StandaloneProfit loss
Net income−¥1.2bn2022-01-01 → 2022-12-31StandaloneNet income loss (5-year summary)
Net income−¥771m2022-01-01 → 2022-06-30StandaloneProfit loss
Total assets¥1.7bnat 2023-06-30StandaloneAssets
Total assets¥2.2bnat 2022-12-31StandaloneAssets
Total assets¥1.9bnat 2022-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥541mat 2023-06-30StandaloneLiabilities
Total liabilities¥425mat 2022-12-31StandaloneLiabilities
Net assets / equity¥1.1bnat 2023-06-30StandaloneNet assets
Net assets / equity¥1.8bnat 2022-12-31StandaloneNet assets
Net assets / equity¥1.5bnat 2022-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.2bnat 2023-06-30StandaloneCash and deposits
Cash and deposits¥1.7bnat 2022-12-31StandaloneCash and deposits
Cash & equivalents¥1.2bnat 2023-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.7bnat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.5bnat 2022-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.8bnat 2021-12-31dStandaloneCash and cash equivalents
Operating cash flow−¥595m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.2bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥660m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow¥82,0002023-01-01 → 2023-06-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥113m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.1bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥341m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-13.72023-01-01 → 2023-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-92023-04-01 → 2023-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-28.262022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-18.172022-01-01 → 2022-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.532022-04-01 → 2022-06-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio67.2%at 2023-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio80.2%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio75.3%at 2022-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued48,503,800at 2023-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued48,423,500at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued43,057,600at 2022-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 16
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-06-30−¥266m
jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segmentsegment profit2023-01-01 → 2023-06-30−¥602m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue2023-01-01 → 2023-06-30¥359m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue external2023-01-01 → 2023-06-30¥359m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentsegment profit2023-01-01 → 2023-06-30¥209m
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-06-30¥359m
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-06-30¥359m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-06-30−¥393m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30−¥239m
jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segmentsegment profit2022-01-01 → 2022-06-30−¥691m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue2022-01-01 → 2022-06-30¥278m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue external2022-01-01 → 2022-06-30¥278m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentsegment profit2022-01-01 → 2022-06-30¥151m
Total Of Reportable Segments And Otherssegment totalrevenue2022-01-01 → 2022-06-30¥278m
Total Of Reportable Segments And Otherssegment totalrevenue external2022-01-01 → 2022-06-30¥278m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-06-30−¥540m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 444
ItemContextValueUnit
Cash and depositsCurrentQuarterInstant_NonConsolidatedMember1245431000JPY
Accounts receivable tradePrior1YearInstant_NonConsolidatedMember115218000JPY
Accounts receivable tradeCurrentQuarterInstant_NonConsolidatedMember96909000JPY
InventoriesPrior1YearInstant_NonConsolidatedMember71478000JPY
InventoriesCurrentQuarterInstant_NonConsolidatedMember59739000JPY
Advance payments tradePrior1YearInstant_NonConsolidatedMember91477000JPY
Advance payments tradeCurrentQuarterInstant_NonConsolidatedMember87603000JPY
Consumption taxes receivablePrior1YearInstant_NonConsolidatedMember29567000JPY
Consumption taxes receivableCurrentQuarterInstant_NonConsolidatedMember6172000JPY
Other caPrior1YearInstant_NonConsolidatedMember57154000JPY
Other caCurrentQuarterInstant_NonConsolidatedMember70846000JPY
Current assetsPrior1YearInstant_NonConsolidatedMember2092166000JPY
Current assetsCurrentQuarterInstant_NonConsolidatedMember1566702000JPY
Machinery and equipmentPrior1YearInstant_NonConsolidatedMember254610000JPY
Machinery and equipmentCurrentQuarterInstant_NonConsolidatedMember242853000JPY
Accumulated depreciation machinery and equipmentPrior1YearInstant_NonConsolidatedMember-252173000JPY
Accumulated depreciation machinery and equipmentCurrentQuarterInstant_NonConsolidatedMember-241051000JPY
Machinery and equipment netPrior1YearInstant_NonConsolidatedMember2437000JPY
Machinery and equipment netCurrentQuarterInstant_NonConsolidatedMember1802000JPY
Tools furniture and fixturesPrior1YearInstant_NonConsolidatedMember97024000JPY
Tools furniture and fixturesCurrentQuarterInstant_NonConsolidatedMember90671000JPY
Accumulated depreciation tools furniture and fixturesPrior1YearInstant_NonConsolidatedMember-97024000JPY
Accumulated depreciation tools furniture and fixturesCurrentQuarterInstant_NonConsolidatedMember-90671000JPY
Tools furniture and fixtures netPrior1YearInstant_NonConsolidatedMember0JPY
Tools furniture and fixtures netCurrentQuarterInstant_NonConsolidatedMember0JPY
Property plant and equipmentPrior1YearInstant_NonConsolidatedMember2437000JPY
Property plant and equipmentCurrentQuarterInstant_NonConsolidatedMember1802000JPY
Long term prepaid expensesPrior1YearInstant_NonConsolidatedMember8055000JPY
Long term prepaid expensesCurrentQuarterInstant_NonConsolidatedMember4235000JPY
Lease and guarantee depositsPrior1YearInstant_NonConsolidatedMember112811000JPY
Lease and guarantee depositsCurrentQuarterInstant_NonConsolidatedMember112811000JPY
Other ioaPrior1YearInstant_NonConsolidatedMember0JPY
Other ioaCurrentQuarterInstant_NonConsolidatedMember0JPY
Investments and other assetsPrior1YearInstant_NonConsolidatedMember120866000JPY
Investments and other assetsCurrentQuarterInstant_NonConsolidatedMember117046000JPY
Noncurrent assetsPrior1YearInstant_NonConsolidatedMember123303000JPY
Noncurrent assetsCurrentQuarterInstant_NonConsolidatedMember118848000JPY
AssetsPrior1YearInstant_NonConsolidatedMember2215470000JPY
AssetsCurrentQuarterInstant_NonConsolidatedMember1685551000JPY
Accounts payable tradePrior1YearInstant_NonConsolidatedMember31866000JPY
Accounts payable tradeCurrentQuarterInstant_NonConsolidatedMember36063000JPY
Short term loans payablePrior1YearInstant_NonConsolidatedMember184000000JPY
Short term loans payableCurrentQuarterInstant_NonConsolidatedMember298300000JPY
Accounts payable otherPrior1YearInstant_NonConsolidatedMember70800000JPY
Accounts payable otherCurrentQuarterInstant_NonConsolidatedMember71510000JPY
Accrued expensesPrior1YearInstant_NonConsolidatedMember26558000JPY
Accrued expensesCurrentQuarterInstant_NonConsolidatedMember27589000JPY
Income taxes payablePrior1YearInstant_NonConsolidatedMember23943000JPY
Income taxes payableCurrentQuarterInstant_NonConsolidatedMember18419000JPY
Advances receivedPrior1YearInstant_NonConsolidatedMember22100000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-06-30pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-06-30pass